Products
Products built on one platform
Each Digistain product applies the same measurement of tumour chemistry to a specific clinical question.
Available
Digistain Breast
Results before the next appointment.
Prognostic recurrence-risk score for HR-positive, HER2-negative, stage I–II invasive breast cancer with 0–3 positive lymph nodes, treated with adjuvant endocrine therapy alone.
Research
Further cancers
Research in kidney, lung and prostate cancer is investigational, not available for clinical use. New products will be listed here once they exist.